The latest research on Migraines is a little bit sad. There’s not enough research being done in migraines. The money is not going into migraines compared to all of the other disease processes. So there’s not much being done from a prevention standpoint. There is some research going into a board of medications and, in fact, a new medication came out last week – it’s not actually a new medication but a new delivery system. It’s a Triptan (like we talked about) but in a patch form, so that should be interesting. A lot of the medications that are being studied now are different types of abortive medications to work on those neurotransmitters that we talked about that cause some of the migraines.